A U Dignass

Summary

Affiliation: Humboldt University
Country: Germany

Publications

  1. ncbi Postprandial abdominal pain, megaloblastic anaemia, and severe weight loss in an 80 year old man
    A U Dignass
    , Medizinische Klinik m S Hepatologie und Gastroenterologie, Augustenburger Platz 1, 13353 Berlin, Germany
    Gut 54:418, 436. 2005
  2. ncbi [Management of perianal fistulizing Crohn's disease: a conservative approach]
    A U Dignass
    Medizinische Klinik m. S. Hepatologie, Gastroenterologie, Endokrinologie und Stoffwechselerkrankungen,
    Dtsch Med Wochenschr 130:1968. 2005
  3. ncbi Mechanisms and modulation of intestinal epithelial repair
    A U Dignass
    Department of Medicine, Charite Campus Virchow Clinic, Berlin, Germany
    Inflamm Bowel Dis 7:68-77. 2001
  4. ncbi Peptide growth factors in the intestine
    A U Dignass
    Department of Medicine, Division of Hepatology and Gastroenterology, Charite Campus Virchow Clinic, Berlin, Germany
    Eur J Gastroenterol Hepatol 13:763-70. 2001
  5. ncbi Functional relevance of activin A in the intestinal epithelium
    A U Dignass
    Department of Hepatology and Gastroenterology, Charite Medical School, Campus Virchow Clinic, Berlin, Germany
    Scand J Gastroenterol 37:936-43. 2002
  6. ncbi Review article: the aetiopathogenesis of inflammatory bowel disease--immunology and repair mechanisms
    A U Dignass
    Department of Medicine, Division of Hepatology and Gastroenterology, Charité Medical School Virchow Hospital, Berlin, Germany
    Aliment Pharmacol Ther 20:9-17. 2004
  7. ncbi Corticosteroids impair intestinal epithelial wound repair mechanisms in vitro
    S Jung
    Dept. of Hepatology and Gastroenterology, , Berlin, Germany
    Scand J Gastroenterol 36:963-70. 2001
  8. ncbi Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells
    D C Baumgart
    Charité Medical Centre Virchow Hospital, Medical School of the Humboldt University, Department of Medicine, Division of Hepatology and Gastroenterology, D 13344 Berlin, Germany
    Gut 54:228-36. 2005
  9. ncbi Adenine nucleotides modulate epithelial wound healing in vitro
    A U Dignass
    Department of Medicine, University of Essen, Germany
    Eur J Clin Invest 28:554-61. 1998
  10. ncbi [Biologic therapy of inflammatory bowel disease]
    D C Baumgart
    Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Interdisziplinäres Stoffwechselzentrum, Universitatsklinikum Charite, Campus Virchow Klinikum, Medizinische Fakultat der Humboldt Universitat zu Berlin
    Z Gastroenterol 41:1017-32. 2003

Collaborators

Detail Information

Publications20

  1. ncbi Postprandial abdominal pain, megaloblastic anaemia, and severe weight loss in an 80 year old man
    A U Dignass
    , Medizinische Klinik m S Hepatologie und Gastroenterologie, Augustenburger Platz 1, 13353 Berlin, Germany
    Gut 54:418, 436. 2005
  2. ncbi [Management of perianal fistulizing Crohn's disease: a conservative approach]
    A U Dignass
    Medizinische Klinik m. S. Hepatologie, Gastroenterologie, Endokrinologie und Stoffwechselerkrankungen,
    Dtsch Med Wochenschr 130:1968. 2005
  3. ncbi Mechanisms and modulation of intestinal epithelial repair
    A U Dignass
    Department of Medicine, Charite Campus Virchow Clinic, Berlin, Germany
    Inflamm Bowel Dis 7:68-77. 2001
    ..Enhancement of intestinal repair mechanisms by regulatory peptides or other modulatory factors may provide future approaches for the treatment of diseases that are characterized by injuries of the epithelial surface...
  4. ncbi Peptide growth factors in the intestine
    A U Dignass
    Department of Medicine, Division of Hepatology and Gastroenterology, Charite Campus Virchow Clinic, Berlin, Germany
    Eur J Gastroenterol Hepatol 13:763-70. 2001
    ..It focuses mainly on classical growth factors rather than interleukins and interferons...
  5. ncbi Functional relevance of activin A in the intestinal epithelium
    A U Dignass
    Department of Hepatology and Gastroenterology, Charite Medical School, Campus Virchow Clinic, Berlin, Germany
    Scand J Gastroenterol 37:936-43. 2002
    ..The aim of this study was to characterize the effects of activin A on intestinal epithelial cell function and to evaluate a potential role in intestinal epithelial wound repair and inflammation...
  6. ncbi Review article: the aetiopathogenesis of inflammatory bowel disease--immunology and repair mechanisms
    A U Dignass
    Department of Medicine, Division of Hepatology and Gastroenterology, Charité Medical School Virchow Hospital, Berlin, Germany
    Aliment Pharmacol Ther 20:9-17. 2004
    ..A better understanding of and enhancement of intestinal repair mechanisms may thus provide future approaches for the treatment of inflammatory bowel disease...
  7. ncbi Corticosteroids impair intestinal epithelial wound repair mechanisms in vitro
    S Jung
    Dept. of Hepatology and Gastroenterology, , Berlin, Germany
    Scand J Gastroenterol 36:963-70. 2001
    ..Thus, impaired intestinal epithelial wound healing under corticosteroid therapy in vivo may be caused by inhibition of intestinal epithelial cell restitution and proliferation...
  8. ncbi Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells
    D C Baumgart
    Charité Medical Centre Virchow Hospital, Medical School of the Humboldt University, Department of Medicine, Division of Hepatology and Gastroenterology, D 13344 Berlin, Germany
    Gut 54:228-36. 2005
    ..Dendritic cells (DC) have been implicated in this process in various animal models, but data on human DC in IBD are very limited...
  9. ncbi Adenine nucleotides modulate epithelial wound healing in vitro
    A U Dignass
    Department of Medicine, University of Essen, Germany
    Eur J Clin Invest 28:554-61. 1998
    ..The mechanism of adenine nucleotide action have not been elucidated. The aim of this study was to characterize the effects of adenine nucleotides on intestinal epithelial wound healing in vitro...
  10. ncbi [Biologic therapy of inflammatory bowel disease]
    D C Baumgart
    Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Interdisziplinäres Stoffwechselzentrum, Universitatsklinikum Charite, Campus Virchow Klinikum, Medizinische Fakultat der Humboldt Universitat zu Berlin
    Z Gastroenterol 41:1017-32. 2003
    ..Based on the data discussed, it seems that biologicals will play an important role in managing inflammatory bowel disease in the near future...
  11. ncbi [Mucosal dendritic cells: reaching out for the unknown (antigen)]
    D C Baumgart
    , Campus Virchow-Klinikum, , Germany
    Z Gastroenterol 40:375-7. 2002
  12. ncbi Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease
    D C Baumgart
    , Medical School of the Humboldt University of Berlin, Department of Medicine, Division of Hepatology and Gastroenterology, Berlin, Germany
    Aliment Pharmacol Ther 17:1273-81. 2003
    ..7%), tremor or paraesthesias (n = 3, 9.7%), hyperkalaemia (n = 1, 3.2%), hypertension (n = 1, 3.2%) and an opportunistic infection (n = 1, 3.2%). CONCLUSION: Oral tacrolimus is safe and effective in refractory inflammatory bowel disease...
  13. ncbi Clinical relevance of transabdominal ultrasonography and magnetic resonance imaging in patients with inflammatory bowel disease of the terminal ileum and large bowel
    M Pascu
    Department of Medicine, , Campus Virchow, Berlin, Germany
    Inflamm Bowel Dis 10:373-82. 2004
    ..CONCLUSION: This study provides strong evidence that US should be considered as a first-choice method for follow-up of patients with IBD of the terminal ileum and large bowel...
  14. ncbi Complication of Waldenstroem's macroglobulinaemia following ERCP
    M Pascu
    , Department of Medicine, Division of Hepatology and Gastroenterology, Augustenburger Platz 1, D-13353 Berlin, Germany
    Gut 53:1793; quiz answer 1812. 2004
  15. ncbi Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways
    A Grabig
    Charite Universitatsmedizin Berlin, Campus Virchow Clinic, Department of Hepatology and Gastroenterology, Augustenburger Platz 1, D 13353 Berlin, Germany
    Infect Immun 74:4075-82. 2006
    ..In conclusion, our data provide evidence that E. coli Nissle 1917 ameliorates experimental induced colitis in mice via TLR-2- and TLR-4-dependent pathways...
  16. ncbi Review on the influence of stress on immune mediators, neuropeptides and hormones with relevance for inflammatory bowel disease
    J H Niess
    Biomedizinisches Forschungszentrum, Campus Virchow-Klinikum, Berlin, Germany
    Digestion 65:131-40. 2002
    ..e. neurotransmitters, hormones and immune cells, which are involved in the response to stress on the one hand, and contribute to the onset, progression or relapses of IBD on the other...
  17. ncbi [Ulcerative colitis. Chronic active course]
    A U Dignass
    Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Charit, , Campus Virchow-Klinikum, Berlin
    Z Gastroenterol 42:1006-10. 2004
  18. ncbi Genetic factors determine extent of bone loss in inflammatory bowel disease
    C M Schulte
    Division of Endocrinology, Department of Internal Medicine, University of Essen, Germany
    Gastroenterology 119:909-20. 2000
    ..The aim of this study was to identify genetic risk factors for rapid bone loss in IBD patients as a model of disease- and inflammation-associated bone loss...
  19. ncbi Uneventful pregnancy and neonatal outcome with tacrolimus in refractory ulcerative colitis
    D C Baumgart
    Gut 54:1822-3. 2005
  20. ncbi Shingles following infliximab infusion
    D C Baumgart
    Ann Rheum Dis 61:661. 2002